Clinical heterogeneity associated with the mitochondrial DNA T8993C point mutation

Pediatric Research

Volumn 39, Issue 5, 1996, Pages 914-917

  Santorelli, Filippo M ^a   Mak, Suk Chun ^a   Vazquez Memije, Marta E ^a   Shanske, Sara ^a   Kranz Eble, Pamela ^a   Jain, Karen D ^b   Bluestone, Daniel L ^c   De Vivo, Darryl C ^a   DiMauro, Salvatore ^a,d  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA;

ARTICLE; ATAXIA; CHILD; DISEASE COURSE; DNA DETERMINATION; DNA SEQUENCE; FEMALE; HUMAN; HUMAN TISSUE; LEIGH DISEASE; MALE; MUSCLE WEAKNESS; PEDIGREE ANALYSIS; POINT MUTATION; PRIORITY JOURNAL; SEIZURE, EPILEPSY AND CONVULSION;

EID: 0029877629     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-199605000-00028     Document Type: Article

References (14)

1. Leigh D 1951 Subacute necrotizing encephalomyelopathy in an infant. J Neurol Neurosurg Psychiatry 14:216-221
2. Willems JI, Monnens LA, Trijbels LMF, Veerkamp JH, Meyer AE, Van Dam K, van Haelst U 1977 Leigh's encephalomyelopathy in a patient with cytochrome c oxidase deficiency in muscle tissue. Pediatrics 60:850-857
3. 1α subunit of human pyruvate dehydrogenase complex. Genomics 4:174-181
4. Van Erven PM, Gabreëls FJ, Ruitenbeek W, Den Hartog MR, Fischer JC, Renier WO, Trijbels JM, Sloof JL, Janssen AJ 1985 Subacute necrotizing encephalomyelopathy (Leigh syndrome) associated with disturbed oxidation of pyruvate, malate and 2-oxoglutarate in muscle and liver. Acta Neurol Scand 72:36-42
5. Tatuch Y, Christodoulou J, Feigenbaum A, Clarke JT, Wherret J, Smith C, Rudd N, Petrova-Benedict R, Robinson BH 1992 Heteroplasmic mtDNA mutation (T → G) at 8993 can cause Leigh's disease when the percentage of abnormal mtDNA is high. Am J Hum Genet 50:852-858
6. Santorelli F, Shanske S, Macaya A, De Vivo DC, DiMauro S 1993 The mutation at nt 8993 of mitochondrial DNA is a common cause of Leigh's syndrome. Ann Neurol 34:827-834
7. Tatuch Y, Robinson BH. 1993 The mitochondrial DNA mutation at 8993 associated with NARP slows the rate of ATP synthesis in isolated lymphoblast mitochondria. Biochem Biophys Res Commun 192:124-128
8. de Vries DD, van Engelen BG, Gabreëls FJ, Ruitenbeek W, van Oost BA 1993 A second missense mutation in the mitochondrial ATPase6 gene in Leigh's syndrome. Ann Neurol 34:410-412
9. Santorelli F M, Shanske S, Jain KD, Tick D, Schon EA, DiMauro S 1994 A T>C mutation at nt 8993 of mitochondrial DNA in a child with Leigh syndrome. Neurology 44:972-974
10. Holt IJ, Harding AE, Petty RKH, Morgan-Hughes JA 1990 A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am J Hum Genet 46:428-433
11. Di Mauro S, Servidei S, Zeviani M, DiRocco M, De Vivo DC, DiDonato S, Uziel G, Berry K, Hoganson G, Johnsen SD, Johnson PC 1987 Cytochrome c oxidase in Leigh syndrome. Ann Neurol 1987 22:498-506
12. i-ATP exchange reaction of submitochondrial particles under the influence of organic solvents. J Biol Chem 259:9472-9478
13. Vazquez-Memije ME, Shanske S, Santorelli FM, Kranz-Eble P, Davidson E, De Vivo DC, DiMauro S 1996 Comparative biochemical studies in fibroblasts from patients with different forms of Leigh syndrome. J Inher Metab Dis (in press)
14. 0-ATP synthase from Escherichia coli. J Biol Chem 268:12250-12252